Evidence map›Paper›PMID 28232581›Full record

ArticleScience (New York, N.Y.)2017

Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.

Wei Lü, Juan Du, April Goehring, Eric Gouaux

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The GluN3-containing NMDA receptors.Channels (Austin, Tex.) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. NMDA Receptors: Next therapeutic targets for Tinnitus?Biochemistry and biophysics reports · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. GluN2A: A Promising Target for Developing Novel Antidepressants.The international journal of neuropsychopharmacology · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Wei LüVollum Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-0214-9090
Juan DuVollum Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-6789-7268
April GoehringVollum Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.ORCID 0000-0002-2592-6956
Eric GouauxVollum Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. gouauxe@ohsu.edu.ORCID 0000-0002-8549-2360
Oregon Health & Science University · USHoward Hughes Medical Institute · US

Funding

3D STRUCTURE/FUNCTION OF LIGAND GATED ION CHANNELSR01NS038631 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 1999 to 2024
$6.7M
Howard Hughes Medical InstituteNINDS NIH HHS R01 NS038631
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Protein MultimerizationAllosteric RegulationAnimalsAntibodies, MonoclonalCryoelectron MicroscopyModels, MolecularNeuronal PlasticityProtein DomainsReceptors, GlutamateReceptors, N-Methyl-D-AspartateXenopus laevisXenopus ProteinsAntibodies, Monoclonalnodal1 protein, XenopusNR2B NMDA receptorReceptors, GlutamateReceptors, N-Methyl-D-AspartateXenopus Proteins

Identifiers

PMID28232581
PMCPMC5568803
OpenAlexW2590999072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.